MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
The Future of Biomarkers in Interventional Oncology
Personalized therapies targeting specific biomarkers and cancer genomics are bringing new hope in the management of cancer.
By Samuel L. Rice, MD, and Constantinos T. Sofocleous, MD, PhD
Studies Support Sirtex SIR-Spheres for Treatment of Liver Cancer Tumors
March 27, 2012—Two studies were recently presented that support radioembolization (selective internal radiation therapy [SIRT]) using yttrium-90 microspheres (SIR-Spheres, Sirtex Medical, Inc., Woburn, MA) for treating cancers of the liver.
SIR Foundation Awards $1.5 Million in Special Research Grants for Interventional Radiology Therapies
December 14, 2022—The Society of Interventional Radiology (SIR) Foundation recently announced it has awarded $1.5 million in grant funding to four projects exploring embolization and interventional oncology research.
SIO Begins ACCLAIM Trial of Ablation to Treat Colorectal Liver Metastases
March 3, 2023—The Society of Interventional Oncology (SIO) announced the commencement of its primary clinical trial, ACCLAIM—Ablation With Confirmation of Colorectal Liver Metastases.
SIO’s ACCLAIM Trial Completes Enrollment
August 5, 2025—The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ACCLAIM—Ablation With Confirmation of Colorectal Liver Metastases.
Interventional Oncology: Precision in Practice
By Ripal Gandhi, MD, FSVM, and David M. Liu, MD, FRCPC, FSIR
